Skip to Main content Skip to Navigation
Conference papers

CUTANEOUS ADVERSE EVENTS IN CHILDREN TREATED WITH BRAF-INHIBITOR VEMURAFENIB FOR REFRACTORY BRAF (V600E) MUTATED LANGERHANS CELL HISTIOCYTOSIS: A EUROPEAN COHORT STUDY

Document type :
Conference papers
Complete list of metadatas

https://www.hal.inserm.fr/inserm-02413491
Contributor : Valerie Taly <>
Submitted on : Monday, December 16, 2019 - 11:21:27 AM
Last modification on : Wednesday, June 24, 2020 - 12:40:12 PM

Identifiers

  • HAL Id : inserm-02413491, version 1

Collections

Citation

Mathilde Tardieu, Sophie Duvert Lehembre, Islam Amine Larabi, Johannes Visser, Caroline Hutter, et al.. CUTANEOUS ADVERSE EVENTS IN CHILDREN TREATED WITH BRAF-INHIBITOR VEMURAFENIB FOR REFRACTORY BRAF (V600E) MUTATED LANGERHANS CELL HISTIOCYTOSIS: A EUROPEAN COHORT STUDY. 34th Annual Meeting of the Histiocyte Society Lisbon, Portugal, October 22–23, 2018, Oct 2019, Lisbon, Portugal. pp.S46-S47. ⟨inserm-02413491⟩

Share

Metrics

Record views

16